Features and Outcomes of Patients With Reactive Arthritis

CompletedOBSERVATIONAL
Enrollment

58

Participants

Timeline

Start Date

February 1, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Arthritis
Interventions
OTHER

Standardised data collection

The following variables will be retrospectively assessed by medical record review using a standardised data collection form:demographics; gender, age; family or personal history of spondyloarthritis, psoriasis, uveitis, inflammatory bowel disease; clinical presentation; mono, oligo or polyarthritis, dactylitis, inflammatory joint pain, enthesopathy, axial symptoms, fever, extra-articular manifestations (conjunctivitis, anterior uveitis, circinate balanitis, skin rash); time interval between infection and musculoskeletal manifestations; causal microorganism if known, or triggering event; HLA-B27; radiographic sacroiliitis; treatments and outcomes (complete recovery at one year follow-up, relapse within 6 months after onset, or spondyloarthritis according to the ASAS criteria).

Trial Locations (2)

Unknown

CHU de Besançon, Besançon

Centre Hospitalier Lyon Sud, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03926429 - Features and Outcomes of Patients With Reactive Arthritis | Biotech Hunter | Biotech Hunter